Peri-operative management of ophthalmic patients taking antithrombotic therapy

International Journal of Clinical Practice

Volumn 65, Issue 3, 2011, Pages 361-371

  Lip, G Y H ^a   Durrani, O M ^b   Roldan, V ^c   Lip, P L ^b   Marin, F ^d   Reuser, T Q ^e,f  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b CITY HOSPITAL   (United Kingdom)

^c HOSPITAL UNIVERSITARIO MORALES MESEGUER   (Spain)

^d HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^e UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^f Midland Eye Institute   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIGLAUCOMA AGENT; ANTITHROMBOCYTIC AGENT; ANTIVITAMIN K; CLOPIDOGREL; D DIMER; FIBRIN; FIBRIN GLUE; FRESH FROZEN PLASMA; HEMOSTATIC AGENT; HEPARIN; PHYTOMENADIONE; PLATELET RICH FIBRIN GEL; PROTHROMBIN; THROMBIN; TICLOPIDINE; UNCLASSIFIED DRUG; VITAMIN K GROUP; WARFARIN;

BARE METAL STENT; BLEEDING; CARDIOVASCULAR RISK; CATARACT EXTRACTION; CHEMOSURGERY; COCHRANE LIBRARY; CONJUNCTIVAL HEMORRHAGE; CORONARY STENT; DENTAL SURGERY; DRUG ELUTING STENT; DRUG SAFETY; ELECTIVE SURGERY; EMBASE; EVIDENCE BASED MEDICINE; EYE SURGERY; FACE SURGERY; GLAUCOMA; GLAUCOMA SURGERY; HEART PROTECTION; HEMOSTASIS; HUMAN; HYPHEMA; INTERNATIONAL NORMALIZED RATIO; INTRAOCULAR PRESSURE; LACRIMAL GLAND; MEDLINE; ORAL SURGERY; PERIBULBAR ANESTHESIA; PERIOPERATIVE PERIOD; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; REBOUND; RETINA HEMORRHAGE; RETINA SURGERY; RETROBULBAR ANESTHESIA; REVIEW; SIDE EFFECT; STROKE; SYSTEMATIC REVIEW; THROMBOEMBOLISM; THROMBOPHILIA; TOPICAL ANESTHESIA; TRABECULECTOMY; VITREOUS BODY;

BLOOD LOSS, SURGICAL; EYE DISEASES; FIBRINOLYTIC AGENTS; HEMOSTASIS, SURGICAL; HUMANS; INTRAOPERATIVE CARE; OPHTHALMOLOGIC SURGICAL PROCEDURES; RISK FACTORS; THROMBOSIS;

EID: 79951646689     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2010.02538.x     Document Type: Review

References (96)

1. Katz J, Feldman MA, Bass EB, et al. Risks and benefits of anticoagulant and antiplatelet medication use before cataract surgery. Ophthalmology 2003; 110: 1784-88. (Pubitemid 37025439)
2. Kitchin AH, Milnes JS,. Longitudinal survey of ischaemic heart disease in a randomly selected sample of the older population. Br Heart J 1997; 39: 889-93.
3. EAFT (European Atrial Fibrillation Trial) Study Group. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet 1993; 342: 1255-62.
4. Fihn SD, Callahan CM, Martin DC, McDonell MB, Henikoff JG, White RH,. The risk for and severity of bleeding complications in elderly patients treated with warfarin. The National Consortium of Anticoagulation Clinics. Ann Intern Med 1996; 124: 124970-9.
5. Schulman S, Beyth RJ, Kearon C, Levine MN,; American College of Chest Physicians. Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133 (Suppl. 6): 257S-298S. (Pubitemid 351892969)
6. Palareti G, Cosmi B,. Bleeding with anticoagulation therapy-who is at risk, and how best to identify such patients. Thromb Haemost 2009; 102: 268-78.
7. Hughes M, Lip GY,; Guideline Development Group for the NICE national clinical guideline for management of atrial fibrillation in primary and secondary care. Risk factors for anticoagulation-related bleeding complications in patients with atrial fibrillation: a systematic review. QJM 2007; 100: 599-6.
8. Lagerstedt CI, Olsson CG, Fagher BO, Oqvist BW, Albrechtsson U,. Need for long-term anticoagulant treatment in symptomatic calf-vein thrombosis. Lancet 1985; 2: 515-8. (Pubitemid 15236478)
9. Levine MN, Hirsh J, Gent M, et al. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis. Thromb Haemost 1995; 74: 606-11.
10. Coon WW, Willis PW III,. Recurrence of venous thromboembolism. Surgery 1973; 73: 823-7.
11. Research Committee of the British Thoracic Society. Optimum duration of anticoagulation for deep-vein thrombosis and pulmonary embolism. Lancet 1992; 340: 873-6.
12. Lip GY, Lim HS,. Atrial fibrillation and stroke prevention. Lancet Neurol 2007; 6 (11): 981-93. (Pubitemid 47566414)
13. Stroke Risk in Atrial Fibrillation Working Group. Independent predictors of stroke in patients with atrial fibrillation: a systematic review. Neurology 2007; 6: 546-54.
14. Cannegieter SC, Rosendaal FR, Briet E,. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation 1994; 89: 635-41. (Pubitemid 24056190)
15. Stein PD, Alpert JS, Bussey HI, Dalen JE, Turpie AG,. Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves. Chest 2001; 119: 220S-27S. (Pubitemid 32154202)
16. Bonow RO, Carabello B, de Leon AC, et al. ACC/AHA guidelines for the management of patients with valvular heart disease. executive summary. A report of the American college of cardiology/american heart association task force on practice guidelines (Committee on Management of Patients with Valvular Heart Disease). J Heart Valve Dis 1998; 7: 672-707.
17. Greaves M, Cohen H, MacHin SJ, Mackie I,. Guidelines on the investigation and management of the antiphospholipid syndrome. Br J Haematol 2000; 109: 704-15. (Pubitemid 30609746)
18. Khamashta MA,. Management of antiphospholipid syndrome. CPD Rheumatology 1999; 1: 22-23.
19. Khamashta MA,. Management of thrombosis in the antiphospholipid syndrome. Lupus 1996; 5: 463-66. (Pubitemid 26354068)
20. Munoz-Rodriguez F, Font J, Cervera R, et al. Clinical study and follow-up of 100 patients with the antiphospholipid syndrome. Semin Arthritis Rheum 1999; 29: 182-90. (Pubitemid 30013282)
21. Ginsberg JS, Wells PS, Brill-Edwards P, et al. Antiphospholipid antibodies and venous thromboembolism. Blood 1995; 86: 3685-91.
22. Grines CL, Bonow RO, Casey DE Jr, et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. J Am Coll Cardiol 2007; 49: 734-9. (Pubitemid 46210116)
23. Palareti G, Legnani C, Poller L, Thomson J,. Warfarin withdrawal. Pharmacokinetic-pharmacodynamic considerations and evidence for 'rebound' hypercoagulability after stopping anticoagulants. Clin Pharmacokinet 1996; 30: 300-13.
24. Genewein U, Haeberli A, Straub PW, Beer JH,. Rebound after cessation of oral anticoagulant therapy: the biochemical evidence. Br J Haematol 1996; 92: 479-85. (Pubitemid 26042945)
25. Palareti G, Legnani C, Guazzaloca G, et al. Activation of blood coagulation after abrupt or stepwise withdrawal of oral anticoagulants - a prospective study. Thromb Haemost 1994; 72: 222-6. (Pubitemid 24251284)
26. Kluft C, Verheijen JH, Jie AF, et al. The postoperative fibrinolytic shutdown: a rapidly reverting acute phase pattern for the fast-acting inhibitor of tissue-type plasminogen activator after trauma. Scand J Clin Lab Invest 1985; 45: 605-10. (Pubitemid 16256133)
27. Rowbotham BJ, Whitaker AN, Harrison J, Murtaugh P, Reasbeck P, Bowie EJ,. Measurement of crosslinked fibrin derivatives in patients undergoing abdominal surgery: use in the diagnosis of postoperative venous thrombosis. Blood Coagul Fibrinolysis 1992; 3: 25-31.
28. Lip GY, Lowe GD,. Fibrin D-dimer: a useful clinical marker of thrombogenesis? Clin Sci (Lond) 1995; 89: 205-14.
29. Carrel TP, Klingenmann W, Mohacsi PJ, Berdat P, Althaus U,. Perioperative bleeding and thromboembolic risk during non-cardiac surgery in patients with mechanical prosthetic heart valves: an institutional review. J Heart Valve Dis 1999; 8: 392-8. (Pubitemid 29396394)
30. Katholi RE, Nolan SP, McGuire LB,. Living with prosthetic heart valves. Subsequent noncardiac operations and the risk of thromboembolism or hemorrhage. Am Heart J 1976; 92: 162-7.
31. Katholi RE, Nolan SP, McGuire LB,. The management of anticoagulation during noncardiac operations in patients with prosthetic heart valves. A prospective study. Am Heart J 1978; 96: 163-5. (Pubitemid 8390630)
32. Tinmouth AH, Morrow BH, Cruickshank MK, Moore PM, Kovacs MJ,. Dalteparin as periprocedure anticoagulation for patients on warfarin and at high risk of thrombosis. Ann Pharmacother 2001; 35: 669-74. (Pubitemid 32523598)
33. Dunn AS, Turpie AG,. Perioperative management of patients receiving oral anticoagulants: a systematic review. Arch Intern Med 2003; 163: 901-8. (Pubitemid 36522737)
34. Douketis JD, Berger PB, Dunn AS, et al. The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 6 (Suppl): 299S-339S. (Pubitemid 351894915)
35. Kallio H, Paloheimo M, Maunuksela EL,. Haemorrhage and risk factors associated with retrobulbar/peribulbar block: a prospective study in 1383 patients. Br J Anaesth 2000; 85: 708-11.
36. Carter K, Miller KM,. Phacoemulsification and lens implantation in patients treated with aspirin or warfarin. J Cataract Refract Surg 1998; 24: 1361-4. (Pubitemid 28473558)
37. Shuler JD, Paschal JF, Holland GN,. Antiplatelet therapy and cataract surgery. J Cataract Refract Surg 1992; 18: 567-71. (Pubitemid 23230149)
38. Gainey SP, Robertson DM, Fay W, Ilstrup D,. Ocular surgery on patients receiving long-term warfarin therapy. Am J Ophthalmol 1989; 108: 142-6. (Pubitemid 19197946)
39. Kumar N, Jivan S, Thomas P, et al. Sub-Tenon's anesthesia with aspirin, warfarin, and clopidogrel. J Cataract Refract Surg 2006; 32: 1022-102.
40. Narendran N, Williamson TH,. The effects of aspirin and warfarin therapy on haemorrhage in vitreoretinal surgery. Acta Ophthalmol Scand 2003; 81: 38-40. (Pubitemid 36621902)
41. Fu AD, McDonald HR, Williams DF, et al. Anticoagulation with warfarin in vitreoretinal surgery. Retina 2007; 27: 290-295. (Pubitemid 46398893)
42. Dayani PN, Grand MG,. Maintenance of warfarin anticoagulation for patients undergoing vitreoretinal surgery. Arch Ophtalmol 2006; 124: 1558-1565. (Pubitemid 44748728)
43. Cobb CJ, Chakrabarti S, Chadha V, Sanders R,. The effect of aspirin and warfarin therapy in trabeculectomy. Eye 2007; 21: 598-603. (Pubitemid 46730707)
44. Hannah IT, Powrle S, Rose GE,. Open lacrimal surgery: a comparison of admission outcome and complications after planned day case or inpatient management. Br J Ophthalmol 1998; 82: 392-396. (Pubitemid 28177149)
45. Hurwitz JJ,. The Lacrimal System. Philadelphia: Lippincott-Raven, 1996: 262-268.
46. Custer PL, Trinkaus KM,. Hemorrhagic complications of oculoplastic surgery. Ophthal Plast Reconstr Surg 2002; 18: 409-15. (Pubitemid 35356219)
47. Otley CC,. Continuation of medically necessary aspirin and warfarin during cutaneous surgery. Mayo Clin Proc 2003; 78: 1392-6. (Pubitemid 37337785)
48. Kargi E, Babuccu O, Hosnuter M, Babuccu B, Altinyazar C,. Complications of minor cutaneous surgery in patients under anticoagulant treatment. Aesthetic Plast Surg 2002; 26: 483-5. (Pubitemid 36919367)
49. Shalom A, Wong L,. Outcome of aspirin use during excision of cutaneous lesions. Ann Plast Surg 2003; 50: 296-8. (Pubitemid 36286425)
50. Ah-Weng A, Natarajan S, Velangi S, Langtry JA,. Preoperative monitoring of warfarin in cutaneous surgery. Br J Dermatol 2003; 149: 386-9. (Pubitemid 37100267)
51. Alcalay J,. Cutaneous surgery in patients receiving warfarin therapy. Dermatol Surg 2001; 27: 756-8. (Pubitemid 32738246)
52. Billingsley EM, Maloney ME,. Intraoperative and postoperative bleeding problems in patients taking warfarin, aspirin, and nonsteroidal antiinflammatory agents. A prospective study. Dermatol Surg 1997; 23: 381-3; discussion 84-5.
53. Otley CC, Fewkes JL, Frank W, Olbricht SM,. Complications of cutaneous surgery in patients who are taking warfarin, aspirin, or nonsteroidal anti-inflammatory drugs. Arch Dermatol 1996; 132: 161-6. (Pubitemid 26058504)
54. Alam M, Goldberg LH,. Serious adverse vascular events associated with perioperative interruption of antiplatelet and anticoagulant therapy. Dermatol Surg 2002; 28: 992-98. (Pubitemid 35424796)
55. Lewis KG, Dufresne RG Jr,. A meta-analysis of complications attributed to anticoagulation among patients following cutaneous surgery. Dermatol Surg 2008; 34: 160-4. (Pubitemid 351164905)
56. Souto JC, Oliver A, Zuazu-Jausoro I, Vives A, Fontcuberta J,. Oral surgery in anticoagulated patients without reducing the dose of oral anticoagulant: a prospective randomized study. J Oral Maxillofac Surg 1996; 54: 27-32; discussion 323. (Pubitemid 26018500)
57. Evans IL, Sayers MS, Gibbons AJ, Price G, Snooks H, Sugar AW,. Can warfarin be continued during dental extraction? Results of a randomized controlled trial. Br J Oral Maxillofac Surg 2002; 40: 248-52. (Pubitemid 34760054)
58. Carter G, Goss AN, Lloyd J, Tocchetti R,. Current concepts of the management of dental extractions for patients taking warfarin. Aust Dent J 2003; 48: 89-96. quiz 138. (Pubitemid 38011254)
59. Della Valle A, Sammartino G, Marenzi G, et al. Prevention of postoperative bleeding in anticoagulated patients undergoing oral surgery: use of platelet-rich plasma gel. J Oral Maxillofac Surg 2003; 61: 1275-8. (Pubitemid 37337744)
60. Nematullah A, Alabousi A, Blanas N, Douketis JD, Sutherland SE,. Dental surgery for patients on anticoagulant therapy with warfarin: a systematic review and meta-analysis. J Can Dent Assoc 2009; 75: 41.
61. Spandorfer JM, Lynch S, Weitz HH, Fertel S, Merli GJ,. Use of enoxaparin for the chronically anticoagulated patient before and after procedures. Am J Cardiol 1999; 84: 478-80. A10. (Pubitemid 29398677)
62. Matsuzaki K, Okabe H, Kajihara N, et al. A prospective study on the timing of discontinuation of aspirin before coronary artery bypass grafting. Nippon Kyobu Geka Gakkai Zasshi 1997; 45: 1710-4. (Pubitemid 27494693)
63. Heit JA,. Perioperative management of the chronically anticoagulated patient. J Thromb Thrombolysis 2001; 12: 81-7. (Pubitemid 33103846)
64. Crowther MA, Julian J, McCarty D, et al. Treatment of warfarin-associated coagulopathy with oral vitamin K: a randomised controlled trial. Lancet 2000; 356: 1551-3.
65. Crowther MA, Wilson S,. Vitamin K for the treatment of asymptomatic coagulopathy associated with oral anticoagulant therapy. J Thromb Thrombolysis 2003; 16: 69-72. (Pubitemid 38477227)
66. Ewards MW Jr, Flemming DC,. Deliberate hypotension. Surg Clin North Am 1975; 55: 947-57.
67. Shepherd J,. Hypotensive anaesthesia and blood loss in orthognathic surgery. Evid Based Dent 2004; 5: 16.
68. Rasgon BM, Cruz RM, Hilsinger RL Jr, et al. Infiltration of epinephrine in tonsillectomy: a randomized, prospective, double-blind study. Laryngoscope 1991; 101: 114-8.
69. Liboon J, Funkhouser W, Terris DJ,. A comparison of mucosal incisions made by scalpel, CO2 laser, electrocautery, and constant-voltage electrocautery. Otolaryngol Head Neck Surg 1997; 116: 379-85. (Pubitemid 27163696)
70. Goldbaum AM, Woog JJ,. The CO2 laser in oculoplastic surgery. Surv Ophthalmol 1997; 42: 255-67.
71. Matras H,. Fibrin seal: the state of the art. J Oral Maxillofac Surg 1985; 43: 605-11. (Pubitemid 15249767)
72. Man D, Plosker H, Winland-Brown JE,. The use of autologous platelet-rich plasma (platelet gel) and autologous platelet-poor plasma (fibrin glue) in cosmetic surgery. Plast Reconstr Surg 2001; 107: 229-37. discussion 38-9.
73. Anitua E, Andia I, Ardanza B, Nurden P, Nurden AT,. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost 2004; 91: 4-15. (Pubitemid 38111215)
74. Laitakari K, Luotonen J,. Autologous and homologous fibrinogen sealants: adhesive strength. Laryngoscope 1989; 99: 974-6. (Pubitemid 19230637)
75. Carless PA, Anthony DM, Henry DA,. Systematic review of the use of fibrin sealant to minimize perioperative allogeneic blood transfusion. Br J Surg 2002; 89: 695-703. (Pubitemid 34595693)
76. Rousou J, Levitsky S, Gonzalez-Lavin L, et al. Randomized clinical trial of fibrin sealant in patients undergoing resternotomy or reoperation after cardiac operations. A multicenter study. J Thorac Cardiovasc Surg 1989; 97: 194-203. (Pubitemid 19061421)
77. Baumann A, Caversaccio M,. Hemostasis in endoscopic sinus surgery using a specific gelatin-thrombin based agent (FloSeal). Rhinology 2003; 41: 244-9. (Pubitemid 38028703)
78. Mathiasen RA, Cruz RM,. Prospective, randomized, controlled clinical trial of a novel matrix hemostatic sealant in children undergoing adenoidectomy. Otolaryngol Head Neck Surg 2004; 131: 601-5. (Pubitemid 39446282)
79. Jorgensen S, Bascom DA, Partsafas A, Wax MK,. The effect of 2 sealants (FloSeal and Tisseel) on fasciocutaneous flap revascularization. Arch Facial Plast Surg 2003; 5: 399-402.
80. Maccabee MS, Trune DR, Hwang PH,. Effects of topically applied biomaterials on paranasal sinus mucosal healing. Am J Rhinol 2003; 17: 203-7. (Pubitemid 37098499)
81. Ellegala DB, Maartens NF, Laws ER Jr,. Use of FloSeal hemostatic sealant in transsphenoidal pituitary surgery: technical note. Neurosurgery 2002; 51: 513-5. discussion 15-6.
82. Vogel A, O'Grady K, Toriumi DM,. Surgical tissue adhesives in facial plastic and reconstructive surgery. Facial Plast Surg 1993; 9: 49-57. (Pubitemid 23075131)
83. Schonauer C, Tessitore E, Barbagallo G, Albanese V, Moraci A,. The use of local agents: bone wax, gelatin, collagen, oxidized cellulose. Eur Spine J 2004; 13 (Suppl 1): S89-96. (Pubitemid 39486142)
84. Weaver FA, Hood DB, Zatina M, Messina L, Badduke B,. Gelatin-thrombin- based hemostatic sealant for intraoperative bleeding in vascular surgery. Ann Vasc Surg 2002; 16: 286-93. (Pubitemid 34761158)
85. Assia EI, Raskin T, Kaiserman I, et al. Effect of aspirin intake on bleeding during cataract surgery. J Cataract Refract Surg 1998; 24: 1243-46. (Pubitemid 28430740)
86. Cannon PD, Dharmar VT,. Minor oral surgical procedures in patients on oral anticoagulants - a controlled study. Aust Dent J 2003; 48: 115-8. (Pubitemid 38016237)
87. Devani P, Lavery KM, Howell CJ,. Dental extractions in patients on warfarin: is alteration of anticoagulant regime necessary? Br J Oral Maxillofac Surg 1998; 36: 107-11. (Pubitemid 28200903)
88. Hall DL, Steen WH Jr, Drummond JW, Byrd WA,. Anticoagulants and cataract surgery. Ophthalmic Surg 1988; 19: 221-2.
89. McCormack P, Simcock PR, Tullo AB,. Management of the anticoagulated patient for ophthalmic surgery. Eye 1993; 7: 749-50. (Pubitemid 24013284)
90. McMahon LB,. Anticoagulants and cataract surgery. J Cararact Refract Surg 1988; 14: 569-71.
91. Morris A, Elder MJ,. Warfarin therapy and cataract surgery. Clin Experiment Ophthalmol 2000; 28: 419-22. (Pubitemid 32050928)
92. Roberts CW, Wood SM, Turner L,. Cataract surgery in anticoagulated patients. J Cararact Refract Surg 1991; 17: 309-12.
93. Robinson GA, Nylander A,. Warfarin and cataract extraction. Br J Ophthalmol 1989; 73: 702-3. (Pubitemid 19236986)
94. Rotenstreich Y, Rubowitz A, Segev F, Jaeger-Roshu S, Assia EI,. Effect of warfarin therapy on bleeding during cataract surgery. J Cataract Refract Surg 2001; 27: 1344-6. (Pubitemid 32889308)
95. Saitoh AK, Saitoh A, Taniguchi H, Amemiya T,. Anticoagulation therapy and ocular surgery. Ophthalmic Surg Lasers 1998; 29: 909-15.
96. Schanbacher CF, Bennett RG,. Postoperative stroke after stopping warfarin for cutaneous surgery. Dermatol Surg 2000; 26: 785-9. (Pubitemid 30620525)